Frontiers | 4T1 Mammary Carcinoma Colonization of Metastatic Niches Is Accelerated by Obesity
JCI Insight - Metastasis regulation by PPARD expression in cancer cells
Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model: Molecular Therapy
Establishment of a murine breast tumor model by subcutaneous or orthotopic implantation
4T1 Syngeneic Murine Model - Altogen Labs
The growth curve of 4T1 tumors in TNBC mouse model in different time... | Download Scientific Diagram
Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis | Anticancer Research
BH is effective in TNBC tumor model. On day 8, 4T1 tumor model mice... | Download Scientific Diagram
Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist | PNAS
OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer | npj Breast Cancer
![PDF] Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/51deb9b98e25b74d8ba50f4d0d65cac52485d5bf/6-Figure5-1.png "PDF] Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis | Semantic Scholar")
PDF] Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis | Semantic Scholar
In vivo orthotopic breast tumor model - by Explicyte Immuno-Oncology
Mouse 4T1 Breast Tumor Model - Pulaski - 2000 - Current Protocols in Immunology - Wiley Online Library
Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors | Journal for ImmunoTherapy of Cancer | Full Text
New shuttle session with our in vivo syngeneic tumor models – for cost-saving efficacy studies - by Explicyte Immuno-Oncology
Marizomib inhibit tumor growth in syngeneic 4T1.2 murine model of TNBC... | Download Scientific Diagram
Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis | Anticancer Research
Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist | PNAS
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response - ScienceDirect
IJMS | Free Full-Text | Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+ MDSCs and Promotion of Circulating IFN-γ+ Myeloid Cells in the 4T1
Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment
Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer | Journal of Experimental & Clinical Cancer Research | Full Text
Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model | Nature Communications
In-vivo antitumor activity of compound 19 in a syngeneic (4T1 induced)... | Download Scientific Diagram
CC inhibits in vivo tumor growth and lung metastasis in 4T1-syngeneic... | Download Scientific Diagram
Cancers | Free Full-Text | Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer
Diindolylmethane Promotes Metabolic Crisis and Enhances the Efficacy of Centchroman in Breast Cancer: A 1H NMR-Based Approach | ACS Omega
